Tolga Doğan

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

|May 27, 2026
The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis.

|Feb 13, 2026
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Dec 30, 2025
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Sep 26, 2022
The Effect of Continuing Chemotherapy after Chemoradiotherapy during the Time to Surgery on Tumor Response and Survival for Local Advanced Rectal Cancer.

Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin

|Nov 03, 2018
Serum ADMA, endothelial dysfunction, and atherosclerosis in hypervolemic hemodialysis patients

İbrahim Doğan, Barış Eser, Sultan Özkurt

Pageof 1

Frequent Collaborators

4 joint publications

Taliha Güçlü Kantar

3 joint publications

Canan Karan

3 joint publications

Melek Özdemir

3 joint publications

Serkan Değirmencioğlu